Figure 2.
Effects of SMOC1 on thrombin-dependent responses in murine platelets. (A) Thrombin-induced phosphorylation of β3-integrin (on Tyr773; pY773) in platelets from WT and SMOC1+/− (+/−) mice; n = 5 animals per group. **P < .01, ANOVA and Bonferroni test. (B) Effect of thrombin (Thr; 0.1 U/mL) on β3-integrin phosphorylation (on Tyr773; pY773) in platelets from SMOC1+/− (+/−) mice pretreated with solvent (Sol) or murine recombinant SMOC1 (rSMOC1; 10 µg/mL, 45 minutes); n = 8 per group. ***P < .001, 2-way ANOVA and Bonferroni test. (C) PAR3 and PAR4 receptor expression in platelets from WT and SMOC1+/− (+/−) mice; n = 4 animals per group. (D) Basal and agonist-induced increases in platelet Ca2+ levels ([Ca2+]i) in platelets from WT and SMOC1+/− (+/−) littermates stimulated with thrombin (Thr; 1 U/mL), a PAR3 agonist (100 µM), or a PAR4 agonist (100 µM); n = 4 animals per group. ***P < .001, 2-way ANOVA and Bonferroni test.

Effects of SMOC1 on thrombin-dependent responses in murine platelets. (A) Thrombin-induced phosphorylation of β3-integrin (on Tyr773; pY773) in platelets from WT and SMOC1+/− (+/−) mice; n = 5 animals per group. **P < .01, ANOVA and Bonferroni test. (B) Effect of thrombin (Thr; 0.1 U/mL) on β3-integrin phosphorylation (on Tyr773; pY773) in platelets from SMOC1+/− (+/−) mice pretreated with solvent (Sol) or murine recombinant SMOC1 (rSMOC1; 10 µg/mL, 45 minutes); n = 8 per group. ***P < .001, 2-way ANOVA and Bonferroni test. (C) PAR3 and PAR4 receptor expression in platelets from WT and SMOC1+/− (+/−) mice; n = 4 animals per group. (D) Basal and agonist-induced increases in platelet Ca2+ levels ([Ca2+]i) in platelets from WT and SMOC1+/− (+/−) littermates stimulated with thrombin (Thr; 1 U/mL), a PAR3 agonist (100 µM), or a PAR4 agonist (100 µM); n = 4 animals per group. ***P < .001, 2-way ANOVA and Bonferroni test.

Close Modal

or Create an Account

Close Modal
Close Modal